Last reviewed · How we verify
NCT03595241: PANACEA
PANACEA Feasibility Study to Assess the Efficacy of BurstDR Spinal Cord Stimulation (SCS)
NA trial testing Spinal cord stimulation by implanted device. in Pain in 30 participants. Status unknown.
1 July 2020
Quick facts
| Lead sponsor | The Leeds Teaching Hospitals NHS Trust |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 9 July 2018 |
| Primary completion | 1 July 2020 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Spinal cord stimulation by implanted device.
Conditions studied
- Pain — all drugs for Pain →
Sponsor
The Leeds Teaching Hospitals NHS Trust
Who can join
Adults 18 to 100, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the effectiveness of Burst DR stimulation as a treatment for persistent abdominal refractory visceral pain secondary to chronic pancreatitis. Abdominal pain is a main symptom in patients with chronic pancreatitis. Patients have a background constant pain with acute episodes needing admissions. Spinal cord stimulation (SCS) is a recognised treatment for neuropathic pain. This involves placing an electric wire in the spine and the use of electricity to manage the pain. This is a pacemaker for controlling pain. Burst DR stimulation delivers a wave form which mimics the way nerves conduct electrical signals, there are short bursts or spikes of stimulation followed by short periods of rest. The key aims and objectives of this study are to evaluate the efficacy of Burst DR SCS as a treatment for persistent pain secondary to chronic pancreatitis
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Spinal Cord Stimulation for Intractable Visceral Pain Originating from the Pelvic and Abdominal Region: A Narrative Review on a Possible New Indication for Patients with Therapy-Resistant Pain.
Bieze M, van Haaps AP, Kapural L, Li S, et al · · 2024 · cited 11× · PMID 38405684 · DOI 10.2147/jpr.s445616
Verify or expand the search:
- PubMed search for NCT03595241
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other The Leeds Teaching Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT06728956 — Assessing NHS ImplemeNTation of an onlinE Resilience Training Acceptance and Commitment Therapy (ACT) Programme to Preve · NA · recruiting
- NCT06533917 — Spinal Cord Stimulation for Chronic Abdominal Pain Patients · NA · recruiting
- NCT06110845 — CLinical Evaluation Of a comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA) · not yet recruiting
- NCT06189131 — The Use of Ventriject to Assess V02Max in Patients Admitted to Hospital in the Emergency Surgery Setting · NA · suspended
- NCT06073314 — Novel Applications for Sarcoma Assessment · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03595241 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Leeds Teaching Hospitals NHS Trust
- Last refreshed: 28 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03595241.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing